1.Risk factors of tracheal reintubation after total aortic arch replacement
Shulian GAO ; Lingxiu ZHONG ; Yamin SONG ; Lixia LIN ; Senpei ZHUANG ; Jian TAO
The Journal of Practical Medicine 2025;41(11):1681-1686
Objective To analyze the risk factors of tracheal reintubation after total aortic arch replace-ment and to provide evidence for the prevention of tracheal reintubation after total aortic arch replacement.Methods From January 1,2019 to June 31,2020,162 patients who underwent total aortic arch replacement in the Department of Cardiac Surgery of a tertiary grade-A hospital in Guangdong Province were randomly selected and divided into reintubation group(n=27)and control group(n=135)based on the occurrence of tracheal reintubation.The risk factors were analyzed by univariate and multivariate logistic regression.Results Among the 162 patients,27 cases(16.7%)had tracheal reintubation.Compared with those in the control group,the length of ICU stay and hospitalization cost in the reintubation group were significantly increased(P<0.001).Univariate analysis indicated that there were significant differences in terms of age,glomerular filtration rate,diabetes mellitus,venti-lator time,pulmonary infection,liver insufficiency,hypoxemia,delirium and cerebrovascular accident(P<0.05).Multivariate analysis showed age(OR=1.069,P=0.038),pulmonary infection(OR=5.227,P=0.047),delirium(OR=7.079,P=0.011),and ventilator use time(OR=1.006,P=0.001)were independent risk factors for tracheal reintubation after total arch replacement.A regression equation was established as follows:[Logit(P)=-8.885+0.066×age+1.654×pulmonary infection+1.957×delirium+0.006×time]of first ventilator use.The area under the ROC curve of the subjects in this model was 0.931(95%CI:0.884~0.979),P<0.001;The results of Hosmer-Lemeshow test(χ2=4.76 and P=0.782)indicated that the model had high accuracy.Conclusion Age,pulmonary infection,delirium and ventilator use time are independent risk factors for tracheal reintubation after total aortic arch replacement.
2.Right ventricular-pulmonary artery connection for palliative treatment of pulmonary atresia with ventricular septal defect in children: A single-center retrospective study
Shuai ZHANG ; Jianrui MA ; Hailong QIU ; Xinjian YAN ; Wen XIE ; Qiushi REN ; Juemin YU ; Tianyu CHEN ; Yong ZHANG ; Xiaohua LI ; Furong LIU ; Shusheng WEN ; Jian ZHUANG ; Qiang GAO ; Jianzheng CEN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2025;32(03):366-371
Objective To compare the benefits and drawbacks of primary patch expansion versus pericardial tube right ventricular-pulmonary artery connection in patients diagnosed with pulmonary atresia with ventricular septal defect (PA/VSD). Methods A retrospective study was conducted on patients diagnosed with PA/VSD who underwent primary right ventricular-pulmonary artery connection surgery at our center between 2010 and 2020. Patients were categorized into two groups based on the type of right ventricular-pulmonary artery connection: a pericardial tube group and a patch expansion group. Clinical data and imaging findings were compared between the two groups. Results A total of 51 patients were included in the study, comprising 31 males and 20 females, with a median age of 12.57 (4.57, 49.67) months. The pericardial tube group included 19 patients with a median age of 17.17 (7.33, 49.67) months, while the patch expansion group consisted of 32 patients with a median age of 8.58 (3.57, 52.72) months. In both groups, the diameter of pulmonary artery, McGoon index, and Nakata index significantly increased after treatment (P<0.001). However, the pericardial tube group exhibited a longer extracorporeal circulation time (P<0.001). The reoperation rate was notably high, with 74.51% of patients requiring further surgical intervention, including 26 (81.25%) patients in the patch expansion group and 12 (63.16%) patients in the pericardial tube group. No statistical differences were observed in long-term cure rates or mortality between the two groups (P>0.005). Conclusion In patients with PA/VSD, both patch expansion and pericardial tube right ventricular-pulmonary artery connection serve as effective initial palliative treatment strategies that promote pulmonary vessel development and provide a favorable foundation for subsequent radical operations. However, compared to the pericardial tube approach, the patch expansion technique is simpler to perform and preserves some intrinsic potential for pulmonary artery development, making it the preferred procedure.
3.Exploration of high-quality development of scientific and technological journals in medical universities:a case study of scientific and technological journals sponsored by Capital Medical University
Ying ZHUANG ; Jian GAO ; Ruifang CHEN ; Fang HUANG
Journal of Capital Medical University 2025;46(1):167-171
Academic journals constitute a vital component of national scientific research and cultural soft power,playing an irreplaceable role in flourishing academic research,fostering cultural innovation,and promoting economic and social development as well as advancements in science and technology.In recent years,China has made a series of policies aimed at promoting the prosperity and development of academic journals and enhancing the country's status and influence in the international academic community.Taking three scientific and technological journals sponsored by Capital Medical University as examples,this paper elucidates a series of measures to facilitate high-quality journal development in the context of the new era,including team building,enhancing journal impact,and initiating enhanced publications.The objective is to provide some preliminary insights into the sustainable and high-quality development of scientific and technological journals at medical universities.
4.Risk factors of tracheal reintubation after total aortic arch replacement
Shulian GAO ; Lingxiu ZHONG ; Yamin SONG ; Lixia LIN ; Senpei ZHUANG ; Jian TAO
The Journal of Practical Medicine 2025;41(11):1681-1686
Objective To analyze the risk factors of tracheal reintubation after total aortic arch replace-ment and to provide evidence for the prevention of tracheal reintubation after total aortic arch replacement.Methods From January 1,2019 to June 31,2020,162 patients who underwent total aortic arch replacement in the Department of Cardiac Surgery of a tertiary grade-A hospital in Guangdong Province were randomly selected and divided into reintubation group(n=27)and control group(n=135)based on the occurrence of tracheal reintubation.The risk factors were analyzed by univariate and multivariate logistic regression.Results Among the 162 patients,27 cases(16.7%)had tracheal reintubation.Compared with those in the control group,the length of ICU stay and hospitalization cost in the reintubation group were significantly increased(P<0.001).Univariate analysis indicated that there were significant differences in terms of age,glomerular filtration rate,diabetes mellitus,venti-lator time,pulmonary infection,liver insufficiency,hypoxemia,delirium and cerebrovascular accident(P<0.05).Multivariate analysis showed age(OR=1.069,P=0.038),pulmonary infection(OR=5.227,P=0.047),delirium(OR=7.079,P=0.011),and ventilator use time(OR=1.006,P=0.001)were independent risk factors for tracheal reintubation after total arch replacement.A regression equation was established as follows:[Logit(P)=-8.885+0.066×age+1.654×pulmonary infection+1.957×delirium+0.006×time]of first ventilator use.The area under the ROC curve of the subjects in this model was 0.931(95%CI:0.884~0.979),P<0.001;The results of Hosmer-Lemeshow test(χ2=4.76 and P=0.782)indicated that the model had high accuracy.Conclusion Age,pulmonary infection,delirium and ventilator use time are independent risk factors for tracheal reintubation after total aortic arch replacement.
5.Exploration of high-quality development of scientific and technological journals in medical universities:a case study of scientific and technological journals sponsored by Capital Medical University
Ying ZHUANG ; Jian GAO ; Ruifang CHEN ; Fang HUANG
Journal of Capital Medical University 2025;46(1):167-171
Academic journals constitute a vital component of national scientific research and cultural soft power,playing an irreplaceable role in flourishing academic research,fostering cultural innovation,and promoting economic and social development as well as advancements in science and technology.In recent years,China has made a series of policies aimed at promoting the prosperity and development of academic journals and enhancing the country's status and influence in the international academic community.Taking three scientific and technological journals sponsored by Capital Medical University as examples,this paper elucidates a series of measures to facilitate high-quality journal development in the context of the new era,including team building,enhancing journal impact,and initiating enhanced publications.The objective is to provide some preliminary insights into the sustainable and high-quality development of scientific and technological journals at medical universities.
6.Application of the " three streams in one" integrated management based on dual code carriers in the whole lifecycle management of medical consumables
Qin ZHANG ; Hui ZHONG ; Xiaokun GAO ; Jian ZHANG ; Shancheng YU ; Feng SHI ; Wenjun GE ; Yue ZHUANG
Chinese Journal of Hospital Administration 2024;40(7):554-557
In order to improve the level of refined management of medical consumables, a hospital used radio frequency identification (RFID) technology to map the unique device identification barcode of medical devices to the supply-processing-distribution (SPD) code, generating a medical consumables RFID tag code with dual code carrier function and a unique serial number. The " three streams in one" mutual integration management mode of hospital information flow, material flow and financial flow was constructed, which realized the whole lifecycle traceability of medical consumables, effectively improved the intelligence and accuracy of inventory control, further optimized the integration function of medical consumables industry and finance, and provided strong data support for the decision-making analysis of hospital operation and management.
7.A multicenter study on effect of delayed chemotherapy on prognosis of Burkitt lymphoma in children
Li SONG ; Ling JIN ; Yonghong ZHANG ; Xiaomei YANG ; Yanlong DUAN ; Mincui ZHENG ; Xiaowen ZHAI ; Ying LIU ; Wei LIU ; Ansheng LIU ; Xiaojun YUAN ; Yunpeng DAI ; Leping ZHANG ; Jian WANG ; Lirong SUN ; Rong LIU ; Baoxi ZHANG ; Lian JIANG ; Huixia WEI ; Kailan CHEN ; Runming JIN ; Xige WANG ; Haixia ZHOU ; Hongmei WANG ; Shushuan ZHUANG ; Chunju ZHOU ; Zifen GAO ; Xiao MU ; Kaihui ZHANG ; Fu LI
Chinese Journal of Pediatrics 2024;62(10):941-948
Objective:To analyze the factors affecting delayed chemotherapy in children with Burkitt lymphoma (BL) and their influence on prognosis.Methods:Retrospective cohort study. Clinical data of 591 children aged ≤18 years with BL from May 2017 to December 2022 in China Net Childhood Lymphoma (CNCL) was collected. The patients were treated according to the protocol CNCL-BL-2017. According to the clinical characteristics, therapeutic regimen was divided into group A, group B and group C .Based on whether the total chemotherapy time was delayed, patients were divided into two groups: the delayed chemotherapy group and the non-delayed chemotherapy group. Based on the total delayed time of chemotherapy, patients in group C were divided into non-delayed chemotherapy group, 1-7 days delayed group and more than 7 days delayed group. Relationships between delayed chemotherapy and gender, age, tumor lysis syndrome before chemotherapy, bone marrow involvement, disease group (B/C group), serum lactate dehydrogenase (LDH) > 4 times than normal, grade Ⅲ-Ⅳ myelosuppression after chemotherapy, minimal residual disease in the interim assessment, and severe infection (including severe pneumonia, sepsis, meningitis, chickenpox, etc.) were analyzed. Logistic analysis was used to identify the relevant factors. Kaplan-Meier method was used to analyze the patients' survival information. Log-Rank was used for comparison between groups.Results:Among 591 patients, 504 were males and 87 were females, the follow-up time was 34.8 (18.6,50.1) months. The 3-year overall survival (OS) rate was (92.5±1.1)%,and the 3-year event-free survival (EFS) rate was (90.5±1.2)%. Seventy-three (12.4%) patients were in delayed chemotherapy group and 518 (87.6%) patients were in non-delayed chemotherapy group. The reasons for chemotherapy delay included 72 cases (98.6%) of severe infection, 65 cases (89.0%) of bone marrow suppression, 35 cases (47.9%) of organ dysfunction, 22 cases (30.1%) of tumor lysis syndrome,etc. There were 7 cases of chemotherapy delay in group B, which were seen in COPADM (vincristine+cyclophosphamide+prednisone+daunorubicin+methotrexate+intrathecal injection,4 cases) and CYM (methotrexate+cytarabine+intrathecal injection,3 cases) stages. There were 66 cases of chemotherapy delay in group C, which were common in COPADM (28 cases) and CYVE 1 (low dose cytarabine+high dose cytarabine+etoposide+methotrexate, 12 cases) stages. Multinomial Logistic regression analysis showed that the age over 10 years old ( OR=0.54,95% CI 0.30-0.93), tumor lysis syndrome before chemotherapy ( OR=0.48,95% CI 0.27-0.84) and grade Ⅲ-Ⅳ myelosuppression after chemotherapy ( OR=0.55,95% CI 0.33-0.91)were independent risk factors for chemotherapy delay.The 3-year OS rate and the 3-year EFS rate of children with Burkitt lymphoma in the delayed chemotherapy group were lower than those in the non-delayed chemotherapy group ((79.4±4.9)% vs. (94.2±1.1)%, (80.2±4.8)% vs. (92.0±1.2)%,both P<0.05). The 3-year OS rate of the group C with chemotherapy delay >7 days (42 cases) was lower than that of the group with chemotherapy delay of 1-7 days (22 cases) and the non-delay group (399 cases) ((76.7±6.9)% vs. (81.8±8.2)% vs. (92.7±1.3)%, P=0.002).The 3-year OS rate of the chemotherapy delay group (9 cases) in the COP (vincristine+cyclophosphamide+prednisone) phase was lower than that of the non-chemotherapy delay group (454 cases) ((66.7±15.7)% vs. (91.3±1.4)%, P=0.005). Similarly, the 3-year OS rate of the chemotherapy delay group (11 cases) in the COPADM1 phase was lower than that of the non-chemotherapy delay group (452 cases) ((63.6±14.5)% vs. (91.5±1.3)%, P=0.001). Conclusions:The delayed chemotherapy was related to the age over 10 years old, tumor lysis syndrome before chemotherapy and grade Ⅲ-Ⅳ myelosuppression after chemotherapy in pediatric BL. There is a significant relationship between delayed chemotherapy and prognosis of BL in children.
9.Preliminary Study on Quantitative Evaluation of Myocardial Fibrosis by CardiacMagnetic Resonance in Patients with Light Chain Cardiac Amyloidosis
Yubo GUO ; Xuezhu WANG ; Xiao LI ; Yajuan GAO ; Zhuang TIAN ; Jian LI ; Li HUO ; Yining WANG
JOURNAL OF RARE DISEASES 2023;2(1):43-49

Result Analysis
Print
Save
E-mail